Swedish Orphan Biovitrum cash flow from investing activities for the twelve months ending September 30, 2024 was $-2.498B, a 43.74% decline year-over-year.
Swedish Orphan Biovitrum annual cash flow from investing activities for 2023 was $-2.066B, a 1311.17% increase from 2022.
Swedish Orphan Biovitrum annual cash flow from investing activities for 2022 was $-0.146B, a 242.05% increase from 2021.
Swedish Orphan Biovitrum annual cash flow from investing activities for 2021 was $-0.043B, a 90.1% decline from 2020.
Swedish Orphan Biovitrum Cash Flow from Investing Activities 2019-2024 | BIOVF